World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 29 November 2021
Main ID:  ISRCTN95873364
Date of registration: 08/04/2016
Prospective Registration: No
Primary sponsor: Paediatric Academic Clinical Program
Public title: Safety of the varying concentrations of milk feeds with food additives and medications
Scientific title: Medications increasing osmolality and compromising the safety of enteral feeding in preterm infants
Date of first enrolment: 20/05/2014
Target sample size: 9
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN95873364
Study type:  Observational
Study design:  Cross-sectional laboratory-based study. (Other)  
Phase:  Not Applicable
Countries of recruitment
Singapore
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Suresh    Chandran
Address:  KK Womens and Childrens Hospital Department Of Neonatology 100 Bukit Timah Road 229899 - Singapore
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Aged 28 to 41 years
2. Delivered their infants preterm (<37 weeks of gestation)
3. Willing to donate their breast milk

Exclusion criteria: Mothers who do not want to participate due to personal reasons.

Age minimum:
Age maximum:
Gender: Female
Health Condition(s) or Problem(s) studied
Osmolality of milk feeds
Not Applicable
Osmolality of milk feeds
Intervention(s)

Participants donate 60-80ml breast milk, which is collected using a breast pump. Pooled expressed breast milk (EBM) is stored in aliquots and is frozen at –5°C to –15°C. Before measuring the osmolality, the frozen EBM is thawed by transferring to the fridge (4°C) for at least 12 hours. Milk osmolality of each aliquot is measured three times at baseline, following which, fortifier and/or medications are added.

Additives added to dilutents:
1. Caffeine citrate (20mg/ml)
2. Folic acid (100mcg/ml)
3. Hydrochlorothiazide (5mg/ml)
4. Omeprazole (2mg/ml)
5. Phenobarbitone (10mg/ml)
6. Sodium phosphate (phosphate 0.52mmol/ml and sodium 0.85 mmol/ml)
7. Calcium glubionate (elemental calcium 115mg/5ml)
8. Domperidone suspension (1mg/ml)
9. Ibuprofen syrup (100mg/5ml)
10. Iron polymaltose drops (1ml = 50mg)
11. Multivitamin drops
12. Potassium dihydrogen phosphate (1mmol/1ml)
13. 20% sodium chloride (Na 3.4mmol/ml)
14. Ursodeoxycholic acid suspension (250mg/5ml)

The osmolality of medications and diluents was measured neat and in a combination of each medication with each diluent via the freezing point depressing method, utilizing an Advanced Micro-osmometer Model 3300 (Advanced Instruments, Inc. Two Technology Way, Norwood, MA 02062). The highest osmolality measurable by this method is 2000 mOsm/kg.
Primary Outcome(s)
Osmolality of expressed breast milk is measured using osmometer at baseline, when additives are added and 4 hours after additives are added.
Secondary Outcome(s)
No secondary outcome measures
Secondary ID(s)
N/A
Source(s) of Monetary Support
Paediatric Academic Clinical Program, KK Women's and Children's Hospital
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Results
Results available: Yes
Date Posted:
Date Completed: 19/05/2015
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history